Coverart for item
The Resource Osteoporosis in focus, Niall Ferguson

Osteoporosis in focus, Niall Ferguson

Label
Osteoporosis in focus
Title
Osteoporosis in focus
Statement of responsibility
Niall Ferguson
Creator
Subject
Language
eng
Summary
"Osteoporosis is a major healthcare problem, affecting the lives of many individuals worldwide. In the UK alone, up to 200,000 osteoporosis-related fractures occur annually -- a figure that is set to increase as the population ages. Pharmacists see many patients with osteoporosis, and thus will benefit from a deeper understanding of this disease." "Osteoporosis in Focus contains a clear, concise discussion of osteoporosis and reviews the role of the pharmacist in counselling patients on their illness, lifestyle and medicines. Chapter topics include prevention, monitoring the condition, clinical interventions, drug treatment, hormone replacement therapy, bisphosphonates, screening and pharmaceutical care. The third book of the 'in Focus' series, Osteoporosis in Focus should be read by all pharmacists as well as by healthcare professionals with an interest in osteoporosis. Book jacket."--BOOK JACKET
Cataloging source
BDS
http://library.link/vocab/creatorName
Ferguson, Niall
Index
no index present
Literary form
non fiction
http://library.link/vocab/subjectName
  • Osteoporosis
  • Osteoporosis
Label
Osteoporosis in focus, Niall Ferguson
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Preface
  • Acknowledgements
  • About the author
  • Abbreviations
  • 1.
  • Introduction.
  • p. 1
  • 2.
  • Osteoporosis.
  • p. 5
  • Definition.
  • p. 5
  • Physiological background.
  • p. 7
  • Epidemiology.
  • p. 19
  • Signs and symptoms.
  • p. 22
  • Types of conditions.
  • p. 22
  • Differential diagnosis.
  • p. 24
  • 3.
  • Prevention of osteoporosis.
  • p. 27
  • General health.
  • p. 27
  • Genetic factors.
  • p. 31
  • Lifestyle factors.
  • p. 34
  • Menopause.
  • p. 36
  • Fractures.
  • p. 38
  • Self-help groups.
  • p. 41
  • 4.
  • Lifestyle factors.
  • p. 43
  • Alcohol.
  • p. 46
  • Cigarette smoking.
  • p. 49
  • Diet.
  • p. 53
  • Exercise.
  • p. 54
  • Other contributing factors.
  • p. 56
  • 5.
  • Monitoring the condition.
  • p. 59
  • Diagnosis.
  • p. 59
  • Radiological techniques.
  • p. 60
  • Biochemical markers.
  • p. 69
  • Bone biopsy.
  • p. 75
  • 6.
  • Clinical interventions.
  • p. 77
  • Medical interventions for osteoporosis.
  • p. 78
  • Surgical interventions for osteoporosis.
  • p. 90
  • 7.
  • Drug treatments.
  • p. 95
  • Prevention.
  • p. 98
  • Active treatment.
  • p. 105
  • Other therapies.
  • p. 109
  • 8.
  • Calcium and vitamin D.
  • p. 111
  • Calcium.
  • p. 111
  • Vitamin D.
  • p. 118
  • Combination therapy.
  • p. 123
  • Drug interactions.
  • p. 124
  • 9.
  • Hormone replacement therapy.
  • p. 127
  • Menopause.
  • p. 127
  • Drug therapy.
  • p. 132
  • Choice of drug and dose.
  • p. 135
  • Timing of replacement therapy.
  • p. 137
  • Selective oestrogen receptor modulators (SERM).
  • p. 143
  • 10.
  • Bisphosphonates.
  • p. 145
  • Theoretical basis of bone loss.
  • p. 145
  • Drug handling.
  • p. 148
  • Fracture rate.
  • p. 150
  • Treatment regimens.
  • p. 151
  • Indications for treatment.
  • p. 152
  • Individual drugs.
  • p. 153
  • 11.
  • future.
  • p. 163
  • Population demographics.
  • p. 163
  • Lifestyle changes.
  • p. 164
  • Health factors.
  • p. 168
  • Monitoring.
  • p. 169
  • Medical interventions.
  • p. 170
  • Health promotion.
  • p. 174
  • 12.
  • Osteoporosis screening.
  • p. 179
  • At-risk groups.
  • p. 181
  • Clinical management.
  • p. 187
  • Opportunities for screening.
  • p. 190
  • Treatment choices.
  • p. 192
  • Clinical audit.
  • p. 193
  • 13.
  • Pharmaceutical care of the osteoporotic patient.
  • p. 195
  • Pharmaceutical care.
  • p. 195
  • Pharmaceutical care in osteoporosis.
  • p. 198
  • Pharmaceutical care projects.
  • p. 205
  • Glossary.
  • p. 209
  • Recommended reading.
  • p. 215
  • Index.
  • p. 217
Control code
b40022062853
Dimensions
24 cm.
Extent
xv, 229 p
Isbn
9780853694830
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Label
Osteoporosis in focus, Niall Ferguson
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Preface
  • Acknowledgements
  • About the author
  • Abbreviations
  • 1.
  • Introduction.
  • p. 1
  • 2.
  • Osteoporosis.
  • p. 5
  • Definition.
  • p. 5
  • Physiological background.
  • p. 7
  • Epidemiology.
  • p. 19
  • Signs and symptoms.
  • p. 22
  • Types of conditions.
  • p. 22
  • Differential diagnosis.
  • p. 24
  • 3.
  • Prevention of osteoporosis.
  • p. 27
  • General health.
  • p. 27
  • Genetic factors.
  • p. 31
  • Lifestyle factors.
  • p. 34
  • Menopause.
  • p. 36
  • Fractures.
  • p. 38
  • Self-help groups.
  • p. 41
  • 4.
  • Lifestyle factors.
  • p. 43
  • Alcohol.
  • p. 46
  • Cigarette smoking.
  • p. 49
  • Diet.
  • p. 53
  • Exercise.
  • p. 54
  • Other contributing factors.
  • p. 56
  • 5.
  • Monitoring the condition.
  • p. 59
  • Diagnosis.
  • p. 59
  • Radiological techniques.
  • p. 60
  • Biochemical markers.
  • p. 69
  • Bone biopsy.
  • p. 75
  • 6.
  • Clinical interventions.
  • p. 77
  • Medical interventions for osteoporosis.
  • p. 78
  • Surgical interventions for osteoporosis.
  • p. 90
  • 7.
  • Drug treatments.
  • p. 95
  • Prevention.
  • p. 98
  • Active treatment.
  • p. 105
  • Other therapies.
  • p. 109
  • 8.
  • Calcium and vitamin D.
  • p. 111
  • Calcium.
  • p. 111
  • Vitamin D.
  • p. 118
  • Combination therapy.
  • p. 123
  • Drug interactions.
  • p. 124
  • 9.
  • Hormone replacement therapy.
  • p. 127
  • Menopause.
  • p. 127
  • Drug therapy.
  • p. 132
  • Choice of drug and dose.
  • p. 135
  • Timing of replacement therapy.
  • p. 137
  • Selective oestrogen receptor modulators (SERM).
  • p. 143
  • 10.
  • Bisphosphonates.
  • p. 145
  • Theoretical basis of bone loss.
  • p. 145
  • Drug handling.
  • p. 148
  • Fracture rate.
  • p. 150
  • Treatment regimens.
  • p. 151
  • Indications for treatment.
  • p. 152
  • Individual drugs.
  • p. 153
  • 11.
  • future.
  • p. 163
  • Population demographics.
  • p. 163
  • Lifestyle changes.
  • p. 164
  • Health factors.
  • p. 168
  • Monitoring.
  • p. 169
  • Medical interventions.
  • p. 170
  • Health promotion.
  • p. 174
  • 12.
  • Osteoporosis screening.
  • p. 179
  • At-risk groups.
  • p. 181
  • Clinical management.
  • p. 187
  • Opportunities for screening.
  • p. 190
  • Treatment choices.
  • p. 192
  • Clinical audit.
  • p. 193
  • 13.
  • Pharmaceutical care of the osteoporotic patient.
  • p. 195
  • Pharmaceutical care.
  • p. 195
  • Pharmaceutical care in osteoporosis.
  • p. 198
  • Pharmaceutical care projects.
  • p. 205
  • Glossary.
  • p. 209
  • Recommended reading.
  • p. 215
  • Index.
  • p. 217
Control code
b40022062853
Dimensions
24 cm.
Extent
xv, 229 p
Isbn
9780853694830
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n

Library Locations

    • Harold Cohen LibraryBorrow it
      Ashton Street, Liverpool, L69 3DA, GB
      53.418074 -2.967913
Processing Feedback ...